GENEVA, Nov. 26 -- ROSE PHARMA INC. (3500 Pacific A venueVirginia Beach, Virginia 23451) filed a patent application (PCT/US2025/029273) for "GLP-1 FORMULATIONS AND THEIR USES" on May 14, 2025. With publication no. WO/2025/240560, the details related to the patent application was published on Nov 20, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): KENNY, Enda (c/o ROSE PHARMA INC.3500 Pacific A venueVirginia Beach, Virginia 23451), WARBURG, Richard (c/o ROSE PHARMA INC.3500 Pacific A venueVirginia Beach, Virginia 23451)
Abstract: The GLP-1 agonist ROSE-010 may be administered in a manner tha...